Avotaciclib trihydrochloride
Avotaciclib trihydrochloride (BEY1107) is a potent, orally bioavailable CDK1 inhibitor. It is a valuable research tool for studying locally advanced and metastatic pancreatic cancer, with applications in both in vitro cell-based assays and in vivo preclinical models.
Product Specifications
CAS Number
1983984-01-5
Product Name Alternative
BEY1107, BEY-1107, BEY1107 trihydrochloride, BEY1107 Trihydrochloride, BEY-1107 Trihydrochloride, BEY 1107 Trihydrochloride, BEY 1107, Avotaciclib, Avotaciclib trihydrochloride, Avotaciclib Trihydrochloride
Field of Research
Cell Biology
Purity
98.90% (May vary between batches)
Smiles
Cl.Cl.Cl.Nc1nccc (n1) -c1ccc (O) c (n1) -c1ccnc (N) n1
Molecular Formula
C13H14Cl3N7O
Molecular Weight
390.65
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941073-500 1x 500 µL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
19105126 3x 1.0µg DNA
Eif2s3y CRISPRa sgRNA lentivector (set of three targets)(Rat)
Sign In for Pricing
View Details